Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 325471000036119 | Mylanta 2go Double Strength chewable tablet, 8 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 398928011000036112 | Mylanta 2go Double Strength (aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 40 mg) chewable tablet, 8 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mylanta 2go Double Strength chewable tablet, 8 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Mylanta 2go Double Strength chewable tablet, 8 | Is a | aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 40 mg chewable tablet, 8 | true | Inferred relationship | Some | ||
| Mylanta 2go Double Strength chewable tablet, 8 | has TPUU | Mylanta 2go Double Strength chewable tablet | true | Inferred relationship | Some | 1 | |
| Mylanta 2go Double Strength chewable tablet, 8 | has TP | Mylanta 2go Double Strength | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Mylanta 2go Double Strength chewable tablet, 8, blister pack | Is a | True | Mylanta 2go Double Strength chewable tablet, 8 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR